Certified by Founder Lodge
RA Capital Management, L.P.
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $160,000,000
19 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing
| Company | Date | Round | Raised |
|---|---|---|---|
 Carmot Therapeutics, Inc. |
July, 26 ,2022 | Series D | $160,000,000 |
 NAPIGEN, INC. |
July, 12 ,2022 | Seed | $7,900,000 |
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Selux Diagnostics, Inc |
March, 01 ,2022 | Series C | $50,000,000 |
 Cortica |
April, 19 ,2023 | Unknown | $75,000,000 |
 Convergent Therapeutics, Inc. |
May, 04 ,2023 | Series A | $90,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Pluton Biosciences |
May, 25 ,2023 | Series A | $16,500,000 |
 SpyGlass Pharma, Inc. |
July, 11 ,2023 | Series C | $90,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 ExcepGen |
August, 25 ,2023 | Unknown | $4,000,000 |
 Superluminal Medicines Inc. |
September, 04 ,2023 | Seed | $33,000,000 |
 Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
 Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 Vaxess Technologies |
September, 14 ,2023 | Unknown | $9,000,000 |
 Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 Commons Clinic |
October, 10 ,2023 | Series A | $19,500,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
